AHS Cancer Control Alberta clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 187 studies whose lead sponsor is AHS Cancer Control Alberta. 31 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 25, 2026.
Keep track of what changes. Save the AHS Cancer Control Alberta studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- Canada
- 173
Focus areas
Conditions AHS Cancer Control Alberta leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 187. Browse all 187 →
- Radiation Treatment of the Prostate That is Specially Adjusted for Each PersonRecruitingNCT07578519Phase 2
- Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With CancerRecruitingNCT06337695Phase 2/3
- Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor PneumonitisRecruitingNCT06860542Phase 2
- Steroid Sparing in Immune Related Hepatitis (irH)RecruitingNCT05345847Not applicable
- Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM PatientsRecruitingNCT04765514Phase 2
- COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid CancerNot yet recruitingNCT06790589Phase 2
- Loratadine for the Prevention of G-CSF-related Bone PainRecruitingNCT05421416Phase 2
- Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal CancerNot yet recruitingNCT07330583Phase 2
- PSMA-PET Directed Radiation Therapy for High-Risk Prostate CancerNot yet recruitingNCT07291557Phase 2
- Chemoradiotherapy for Advanced Esophageal CancerRecruitingNCT02297217Phase 2
- Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)Not yet recruitingNCT05128734Phase 2
- A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home EnvironmentRecruitingNCT04268199Phase 2
- This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung CancerNot yet recruitingNCT06882174Phase 2
- Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal CancerRecruitingNCT05040815Phase 2
- SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver MetastasesRecruitingNCT05775146Phase 2
- Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)RecruitingNCT05663775Phase 2
- Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal LesionsRecruitingNCT04242589Phase 2
- Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)RecruitingNCT05451043Phase 2
- Tamoxifen Versus Etoposide After First Recurrence in GBM PatientsRecruitingNCT04765098Phase 2
- PET/MRI in Rectal CancerNot yet recruitingNCT06057831Phase 2
- Immune-Mediated Pathophysiology And Clinical Triage ProgramRecruitingNCT04354649Phase 2
- Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)RecruitingNCT05413473Phase 1/2
- Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung CancerRecruitingNCT04952480Phase 2
- MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)RecruitingNCT04358913Not applicable
- Pilot Trial for Treatment of Recurrent GlioblastomaRecruitingNCT05432518Early Phase 1
- Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)RecruitingNCT05407987Phase 3
- Nutritional Supplementation in Head and Neck CancersRecruitingNCT05379712Phase 2
- High Heated Humidity in Stem Cell TransplantRecruitingNCT05358262Phase 2
- A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction AdenocarcinomaRecruitingNCT05370144Not applicable
- p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)RecruitingNCT04104945Not applicable
- A Study of Genetic Based Chemotherapy Dosing for Breast Cancer PatientsRecruitingNCT01740271Phase 2
- mHealth Physical Activity Intervention for Young Cancer SurvivorsActive, not recruitingNCT04765241Not applicable
- A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to UseTerminatedNCT03145857Phase 1/2
- Study of Niacin in GlioblastomaActive, not recruitingNCT04677049Phase 1/2
- A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine TumoursSuspendedNCT01876771Phase 2
- Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)CompletedNCT03391973Phase 2
- GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)Active, not recruitingNCT06789081Early Phase 1
- A Research Study to Collect Patient Reported Outcomes Using Electronic SurveysTerminatedNCT04990895Not applicable
- Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)TerminatedNCT06001125Phase 2
- GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part SarcomaCompletedNCT06827886Early Phase 1
- Pre- Versus Post-operative SRS for Resectable Brain MetastasesTerminatedNCT04474925Phase 3
- HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD ProphylaxisTerminatedNCT03456817Phase 2
- Conventional Versus Hypofractionated Radiation in High Risk Prostate PatientsTerminatedNCT01488968Not applicable
- Tomosynthesis in Screening MammographyCompletedNCT01086241Not applicable
- Prognostic Indicators for Radiation-induced Breast FibrosisTerminatedNCT05031065
- A Nutritional Supplement to Support People With Non-small Cell Lung CancerActive, not recruitingNCT04175769Not applicable
- Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain MetastasesTerminatedNCT04461418Phase 2
- Exercise and Compression for LymphedemaCompletedNCT05022823Not applicable
- The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical RadiotherapyTerminatedNCT03737721Phase 2
- Unilateral Neck Radiotherapy in Head and Neck CancerTerminatedNCT03622164Not applicable